Table 5.
Genome quantification of DNA and RNA viruses treated with CAC-717 for 60 min.
| Genome | Envelope | Family | Viruses | Solution | |
|---|---|---|---|---|---|
| CAC-717 | DW | ||||
| DNA | + | Herpesviridae | PrV | 68.8 ± 3.5 1 | 121.4 ± 7.2 |
| CHV-1 | 82.4 ± 2.8 | 96.6 ± 5.0 | |||
| IBRV | 35.8 ± 4.6 | 91.4 ± 7.5 | |||
| EHV-1 | 8.7 ± 0.4 | 106.8 ±0.9 | |||
| − | Parvoviridae | CPV-2 | 131.0 ± 12.5 | 79.6 ± 2.1 | |
| Adenoviridae | BAdV-7 | 70.2 ± 5.6 | 93.4 ± 2.0 | ||
| RNA | + | Paramyxoviridae | BPIV-3 | 3.0 ± 0.3 | 90.6± 2.1 |
| BRSV | 0.0 ± 0.0 | 114.6 ± 3.4 | |||
| CDV | 0.0 ± 0.0 | 102.5 ± 1.2 | |||
| NDV | 2.9 ± 0.1 | 119.4 ± 5.4 | |||
| Rhabdoviridae | VSV | 0.0 ± 0.0 | 105.1 ± 9.9 | ||
| Coronaviridae | SARS-CoV-2 | 88.5 ± 0.8 | 108.7 ± 0.7 | ||
| BCoV | 2.4 ± 0.3 | 97.4 ± 4.7 | |||
| Flaviviridae | BVDV-I | 68.4 ± 2.9 | 109.6 ± 11.8 | ||
| BVDV-II | 22.0 ± 1.6 | 100.4 ± 2.5 | |||
| Orthomyxoviridae | SwIV (H1N1) | 6.6 ± 0.1 | 107.2 ± 0.8 | ||
| EqIV (H3N8) | 0.3 ± 0.0 | 40.3 ± 0.4 | |||
| − | Picornaviridae | BRBV | 0.6 ± 0.1 | 75.0 ± 2.4 | |
| Caliciviridae | FCV | 0.0 ± 0.0 | 82.0± 1.3 | ||
| Reoviridae | BRoV | 0.0 ± 0.0 | 137.1 ± 3.3 | ||
| BuORV | 0.1 ± 0.0 | 134.1 ± 3.1 | |||
1. Values are the mean ± SE percentage of the copy number of genomes extracted from samples treated with maintenance medium.